16 November 2020 Awareness Week on Alcohol-Related Harm (AWARH) takes place yearly. It serves to raise awareness among EU policymakers of the types of harm caused by alcohol, to increase awareness about the need to address alcohol-related harm in Europe,…
An extraordinary year, such as 2020, calls for increased connection with and accountability to our community. EASL wants to hear from you, our members, about what you want and need from us as a professional association, at the Extraordinary General…
As a fully digital three-day event, Digital ILC 2020 brought together thousands of delegates from all over the world. EASL invited you, the delegates, to take part in the first ever EASL Share competition. We asked you to submit creative…
On 4 November 2020, EASL held its first online Patient Forum, a vibrant exchange exploring synergies between our association of professionals and regional patient organisations engaged in the fight against liver disease. Scientists, practitioners, and patient advocates discussed two EASL…
Save the date and register for the first webinar. Free access. Topic: Sarcopenia in chronic liver disease When: Thursday, 12th Nov. 2020 from 8 pm to 9.30 pm CET Learning objectives: To gain an understanding of the pathophysiology of sarcopenia…
AMRA Medical Research Results Support Strengthening Sarcopenia Guidelines AMRA Medical’s research publication in JHEP Reports details the link between MRI-based adverse muscle composition and NAFLD metabolic comordidity & poor function. Linköping, Sweden, October 28, 2020 AMRA’s research, in collaboration with…
From ground-breaking discoveries to the Nobel Prize 2020, hepatology is cutting edge. This autumn, EASL has a crop of exciting fellowships on offer, to foster the next generation of bright minds. Are you a young scientist on a dynamic career…
5 October 2020 The Nobel Prize in Physiology or Medicine 2020 has been awarded jointly to Harvey J. Alter, Michael Houghton, and Charles M. Rice for the discovery of hepatitis C virus The 2020 Nobel Prize for Physiology and Medicine…
An international study led by researchers at Oxford University Hospitals NHS Foundation Trust has shown that patients with cirrhosis are at increased risk of dying as a result of COVID-19. Oxford, October 6, 2020 – The study, published in the…
19 September 2020 EASL is part of a joint initiative on the impact of COVID-19 on liver transplantation, aiming to explore how patients, healthcare professionals, and liver transplant centres across the world are affected – in their clinical care and…